Shopping Cart
- Remove All
Your shopping cart is currently empty
FTISADTSK is an endogenous stable signature peptide derived from Trastuzumab, accurately assessed using selected reaction monitoring (SRM).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | Backorder |
| Description | FTISADTSK is an endogenous stable signature peptide derived from Trastuzumab, accurately assessed using selected reaction monitoring (SRM). |
| Molecular Weight | 969.06 |
| Formula | C42H68N10O16 |
| Cas No. | 1431957-73-1 |
| Sequence Short | FTISADTSK |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.